SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 288 filers reported holding SEATTLE GENETICS INC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $2,860,000 | +15.8% | 14,625 | +0.5% | 0.26% | +7.9% |
| Q2 2020 | $2,470,000 | +51.9% | 14,556 | +3.3% | 0.24% | +24.5% |
| Q1 2020 | $1,626,000 | +3.0% | 14,091 | +2.0% | 0.19% | +33.3% |
| Q4 2019 | $1,578,000 | +39.6% | 13,810 | +4.3% | 0.14% | +29.7% |
| Q3 2019 | $1,130,000 | +33.6% | 13,235 | +8.3% | 0.11% | +32.1% |
| Q2 2019 | $846,000 | +0.8% | 12,225 | +6.7% | 0.08% | -3.4% |
| Q1 2019 | $839,000 | +30.9% | 11,460 | +1.3% | 0.09% | +14.5% |
| Q4 2018 | $641,000 | -25.6% | 11,315 | +1.3% | 0.08% | -14.6% |
| Q3 2018 | $862,000 | +17.3% | 11,171 | +0.9% | 0.09% | +9.9% |
| Q2 2018 | $735,000 | +27.6% | 11,076 | +0.6% | 0.08% | +26.6% |
| Q1 2018 | $576,000 | -5.3% | 11,006 | -3.1% | 0.06% | -1.5% |
| Q4 2017 | $608,000 | +0.8% | 11,356 | +2.4% | 0.06% | -4.4% |
| Q3 2017 | $603,000 | +16.6% | 11,086 | +10.8% | 0.07% | +11.5% |
| Q2 2017 | $517,000 | -13.5% | 10,001 | +5.2% | 0.06% | -17.6% |
| Q1 2017 | $598,000 | +20.3% | 9,506 | +1.0% | 0.07% | +15.6% |
| Q4 2016 | $497,000 | +7.3% | 9,411 | +9.7% | 0.06% | +4.9% |
| Q3 2016 | $463,000 | +43.3% | 8,581 | +7.2% | 0.06% | +35.6% |
| Q2 2016 | $323,000 | +21.4% | 8,001 | +5.4% | 0.04% | +18.4% |
| Q1 2016 | $266,000 | – | 7,588 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |